A. Burke‐Gaffney

Modulation of human endothelial cell permeability by combinations of the cytokines interleukin-1 alpha/beta, tumor necrosis factor-alpha and interferon-gamma.

A. Keenan, A. Burke‐Gaffney, A. Burke-Gaffney, 1993, Immunopharmacology.

Drug-Coated Balloon-Only Percutaneous Coronary Intervention for the Treatment of De Novo Coronary Artery Disease: A Systematic Review

A. Burke‐Gaffney, R. Bogle, H. Mohiaddin, 2018, Cardiology and Therapy.

Thioredoxin: friend or foe in human disease?

M. Callister, Hajime Nakamura, A. Burke‐Gaffney, 2005, Trends in pharmacological sciences.

Drug-eluting balloons with provisional bail-out or adjunctive stenting in de novo coronary artery lesions-a systematic review and meta-analysis.

A. Burke‐Gaffney, R. Bogle, Smit Patel, 2018, Cardiovascular diagnosis and therapy.

The RAGE axis in systemic inflammation, acute lung injury and myocardial dysfunction: an important therapeutic target?

T. Evans, B. Creagh-Brown, A. Burke‐Gaffney, 2010, Intensive Care Medicine.